Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Inflammatory Bowel Diseases
|
March 22, 2012
New perspectives of an old cytokine
Ali Raza, Mohamed T Shata
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 11, 2008
The mystery of hepatitis E seroprevalence in developed countries: is there subclinical infection due to hepatitis E virus?
Mohamed T Shata, Udayakumar Navaneethan
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 30, 2008
Hepatitis E and pregnancy: understanding the pathogenesis
Udayakumar Navaneethan, Mayar Al Mohajer, Mohamed T Shata
Clinical and Vaccine Immunology : CVI
|
April 24, 2009
Interleukin-12 is the optimum cytokine to expand human Th17 cells in vitro
Soad Nady, James Ignatz-Hoover, Mohamed T Shata
Journal of Immunology (Baltimore, Md. : 1950)
|
October 22, 2003
M cell DNA vaccination for CTL immunity to HIV
Xinhai Wang, David M Hone, Asmahan Haddad, et al.
Vaccine
|
November 6, 2010
Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination
Ramu A Subbramanian, Saleem Basha, Mohamed T Shata, et al.
Emerging Infectious Diseases
|
February 26, 2009
Hepatitis E virus antibodies in patients with chronic liver disease
Muslim Atiq, Norah J Shire, Anna Barrett, et al.
Human Immunology
|
July 24, 2010
Age-related changes in magnitude and diversity of cross-reactive CD4+ T-cell responses to the novel pandemic H1N1 influenza hemagglutinin
Ramu A Subbramanian, Saleem Basha, Rebecca C Brady, et al.
The Journal of Infectious Diseases
|
October 20, 2005
Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model
Alfred M Prince, Betsy Brotman, Dong-Hun Lee, et al.
Vaccine
|
May 2, 2002
Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1
Anthony L Devico, Timothy R Fouts, Mohamed T Shata, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Inflammatory Bowel Diseases
|
March 22, 2012
New perspectives of an old cytokine
Ali Raza, Mohamed T Shata
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 11, 2008
The mystery of hepatitis E seroprevalence in developed countries: is there subclinical infection due to hepatitis E virus?
Mohamed T Shata, Udayakumar Navaneethan
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 30, 2008
Hepatitis E and pregnancy: understanding the pathogenesis
Udayakumar Navaneethan, Mayar Al Mohajer, Mohamed T Shata
Clinical and Vaccine Immunology : CVI
|
April 24, 2009
Interleukin-12 is the optimum cytokine to expand human Th17 cells in vitro
Soad Nady, James Ignatz-Hoover, Mohamed T Shata
Journal of Immunology (Baltimore, Md. : 1950)
|
October 22, 2003
M cell DNA vaccination for CTL immunity to HIV
Xinhai Wang, David M Hone, Asmahan Haddad, et al.
Vaccine
|
November 6, 2010
Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination
Ramu A Subbramanian, Saleem Basha, Mohamed T Shata, et al.
Emerging Infectious Diseases
|
February 26, 2009
Hepatitis E virus antibodies in patients with chronic liver disease
Muslim Atiq, Norah J Shire, Anna Barrett, et al.
Human Immunology
|
July 24, 2010
Age-related changes in magnitude and diversity of cross-reactive CD4+ T-cell responses to the novel pandemic H1N1 influenza hemagglutinin
Ramu A Subbramanian, Saleem Basha, Rebecca C Brady, et al.
The Journal of Infectious Diseases
|
October 20, 2005
Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model
Alfred M Prince, Betsy Brotman, Dong-Hun Lee, et al.
Vaccine
|
May 2, 2002
Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1
Anthony L Devico, Timothy R Fouts, Mohamed T Shata, et al.
Page
of 2